Summary
In juvenile chronic arthritis (JCA) the indices of disease activity, such as joint swelling, pain, tenderness, and limitation of motion, may poorly correlate with the degree of functional impairment. Since the improvement of functional capacity is one of the main objectives of treatment, we evaluated the effect of methotrexate (MTX) in 29 children with JCA by assessing both the articular indices and a functional status measure. After 6 months of therapy, 15 of the 29 patients had a significant (≥50%) reduction in the number of joints with active arthritis and/or the articular severity score and were then judged as responders, while 14 did not respond to MTX. In the responder group, the median functional index score decreased from 17 (range: 13–27) at baseline to 13 (range: 13–15) at 6 months (p<0.001); the median score of the non-responder group was 20 both at baseline and at 6 months (ranges: 14–27, and 13–36, respectively). These results show an improvement of functional impairment in those patients who respond to MTX according to the conventional indices of articular inflammation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Truckenbrodt, H., Hafner, R. Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective study. Arthritis Rheum 1986, 29, 801–807.
Speckmaier, M., Findeisen, J., Woo, P., et al. Low-dose methotrexate in systemic onset juvenile chronic arthritis. Clin Exp Rheumatol 1989, 7, 647–650.
Wallace, C.A., Bleyer, W.A., Sherry, D.D., Salmonson, K.L., Wedgwood, R.J. Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Arthritis Rheum 1989, 32, 677–681.
Rose, C.D., Singsen, B.H., Eichenfield, A.H., Goldsmith, D.P., Athreya, B.H. Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr 1990, 117, 653–659.
Martini, A., Ravelli, A., Viola, S., Burgio, G.R. Methotrexate hepatotoxic effects in children with juvenile rheumatoid arthritis. J Pediatr 1991, 119, 333–334.
Halle, F., Prieur, A.M. Evaluation of methotrexate in the treatment of juvenile chronic arthritis according to the subtype. Clin Exp Rheumatol 1991, 9, 297–302.
Giannini, E.H., Brewer, E.J., Kuzmina, N., et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. N Engl J Med 1992, 326, 1043–1049.
Lovell, D.J. Newer functional outcome measurements in juvenile rheumatoid arthritis: a progress report. J Rheumatol 1992, 19 (suppl 33), 28–31.
White, P.H., Ansell, B.M. Methotrexate for juvenile rheumatoid arthritis. N Engl J Med 1992, 326, 1077–1078.
Tugwell, P., Bombardier, C., Buchanan, W.W. et al. Methotrexate in rheumatoid arthritis: impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. Arch Intern Med 1990, 150, 59–62.
Wood P.H.N. Special meeting on: nomenclature and classification of arthritis in children. In: The Care of Rheumatic Children, Ed.: Munthe, E., Basle, EULAR Publishers, 1987, 47.
Ravelli, A., Di Fuccia, G., Molinaro, M., et al. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis. J Rheumatol 1993, 20, 1573–1577.
Ravelli, A., Ramenghi, B., Di Fuccia, G., Ruperto, N., Zonta, L., Martini, A. Factors associated with response to methotrexate in systemic-onset juvenile chronic arthritis. Acta Paediatr 1994, 83, 428–432.
Lee, P., Jasani, M.K., Dick, C., Buchanan, W.W. Evaluation of a functional index in rheumatoid arthritis. Scand J Rheumatol 1973, 2, 71–77.
Steinbrocker, O., Traeger, C.N., Batterman, R.C. Therapeutic criteria in rheumatoid arthritis. JAMA 1949, 140, 659–662.
Howe, S., Levinson, J., Shear, E., et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. Arthritis Rheum 1991, 34, 873–880.
Wright, V., Crombie, V., Law, M., Goldsmith, C., Dent, P., Shore, A. Development of a selfreport functional status index for children and teens with juvenile arthritis (abstract). J Rheumatol 1992, 19 (suppl 33). 125.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ravelli, A., Viola, S., Ramenghi, B. et al. Evaluation of response to methotrexate by a functional index in juvenile chronic arthritis. Clin Rheumatol 14, 322–326 (1995). https://doi.org/10.1007/BF02208347
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02208347